BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35404538)

  • 1. Upregulated YAP promotes oncogenic CTNNB1 expression contributing to molecular pathology of hepatoblastoma.
    Lu S; Jiang M; Chen Q; Luo X; Cao Z; Huang H; Zheng M; Du J
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29705. PubMed ID: 35404538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.
    Zhang J; Liu P; Tao J; Wang P; Zhang Y; Song X; Che L; Sumazin P; Ribback S; Kiss A; Schaff Z; Cigliano A; Dombrowski F; Cossu C; Pascale RM; Calvisi DF; Monga SP; Chen X
    Am J Pathol; 2019 May; 189(5):1077-1090. PubMed ID: 30794805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase separation of YAP mediated by coiled-coil domain promotes hepatoblastoma proliferation via activation of transcription.
    Mao S; Liu Q; Wu H; Zhu J; Xie Y; Ma J; Zhen N; Pan Q
    J Gastroenterol Hepatol; 2023 Aug; 38(8):1398-1407. PubMed ID: 36908026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.
    Zhang W; Meyfeldt J; Wang H; Kulkarni S; Lu J; Mandel JA; Marburger B; Liu Y; Gorka JE; Ranganathan S; Prochownik EV
    J Biol Chem; 2019 Nov; 294(46):17524-17542. PubMed ID: 31597698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK9 is dispensable for YAP-driven hepatoblastoma development.
    Chen X; Kiss A; Schaff Z; Evert K; Zhang Y; Zhong S; Wang J; Evert M; Calvisi DF; Chen X
    Pediatr Blood Cancer; 2020 May; 67(5):e28221. PubMed ID: 32124532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma.
    Zhang Y; Xu H; Cui G; Liang B; Chen X; Ko S; Affo S; Song X; Liao Y; Feng J; Wang P; Wang H; Xu M; Wang J; Pes GM; Ribback S; Zeng Y; Singhi A; Schwabe RF; Monga SP; Evert M; Tang L; Calvisi DF; Chen X
    Gastroenterology; 2022 Aug; 163(2):481-494. PubMed ID: 35489428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.
    Matsumoto S; Yamamichi T; Shinzawa K; Kasahara Y; Nojima S; Kodama T; Obika S; Takehara T; Morii E; Okuyama H; Kikuchi A
    Nat Commun; 2019 Aug; 10(1):3882. PubMed ID: 31462641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma Pathogenesis.
    Min Q; Molina L; Li J; Adebayo Michael AO; Russell JO; Preziosi ME; Singh S; Poddar M; Matz-Soja M; Ranganathan S; Bell AW; Gebhardt R; Gaunitz F; Yu J; Tao J; Monga SP
    Am J Pathol; 2019 May; 189(5):1091-1104. PubMed ID: 30794807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer.
    Quinn HM; Vogel R; Popp O; Mertins P; Lan L; Messerschmidt C; Landshammer A; Lisek K; Château-Joubert S; Marangoni E; Koren E; Fuchs Y; Birchmeier W
    Cancer Res; 2021 Apr; 81(8):2116-2127. PubMed ID: 33574090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OTUD6A orchestrates complex modulation of TEAD4-mediated transcriptional programs.
    Kim HJ; Choi Y; Lee Y; Hwangbo M; Kim J
    FEBS Lett; 2024 May; 598(9):1045-1060. PubMed ID: 38594215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
    Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
    Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1).
    He S; Zhang H; Xiao Z; Bhushan S; Gao K; Wang W
    Bioengineered; 2021 Dec; 12(1):601-614. PubMed ID: 33517828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
    Liang B; Zhou Y; Qian M; Xu M; Wang J; Zhang Y; Song X; Wang H; Lin S; Ren C; Monga SP; Wang B; Evert M; Chen Y; Chen X; Huang Z; Calvisi DF; Chen X
    J Hepatol; 2021 Jul; 75(1):120-131. PubMed ID: 33577921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HGF/c-Met related activation of β-catenin in hepatoblastoma.
    Purcell R; Childs M; Maibach R; Miles C; Turner C; Zimmermann A; Sullivan M
    J Exp Clin Cancer Res; 2011 Oct; 30(1):96. PubMed ID: 21992464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Derived Mutant Forms of NFE2L2/NRF2 Drive Aggressive Murine Hepatoblastomas.
    Wang H; Lu J; Mandel JA; Zhang W; Schwalbe M; Gorka J; Liu Y; Marburger B; Wang J; Ranganathan S; Prochownik EV
    Cell Mol Gastroenterol Hepatol; 2021; 12(1):199-228. PubMed ID: 33618031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans.
    Zhang S; Zhang J; Evert K; Li X; Liu P; Kiss A; Schaff Z; Ament C; Zhang Y; Serra M; Evert M; Chen N; Xu F; Chen X; Tao J; Calvisi DF; Cigliano A
    Am J Pathol; 2020 Jul; 190(7):1397-1413. PubMed ID: 32283103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
    Canal F; Anthony E; Lescure A; Del Nery E; Camonis J; Perez F; Ragazzon B; Perret C
    BMC Cancer; 2015 Dec; 15():1020. PubMed ID: 26715116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.
    Sanceau J; Poupel L; Joubel C; Lagoutte I; Caruso S; Pinto S; Desbois-Mouthon C; Godard C; Hamimi A; Montmory E; Dulary C; Chantalat S; Roehrig A; Muret K; Saint-Pierre B; Deleuze JF; Mouillet-Richard S; Forné T; Grosset CF; Zucman-Rossi J; Colnot S; Gougelet A
    Mol Ther; 2024 Apr; 32(4):1125-1143. PubMed ID: 38311851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.
    Sha YL; Liu S; Yan WW; Dong B
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31511432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
    Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
    J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.